KHN Morning Briefing

Summaries of health policy coverage from major news organizations.

Pentagon Advisor’s Biotech Firm Reaps Millions For Anthrax Drug

Los Angeles Times: Anthrax Drug Brings $334 Million To Pentagon Advisor's Biotech Firm
Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a major threat to national security. Terrorists, he warned, could easily engineer a devastating killer germ: a form of anthrax resistant to common antibiotics. … Danzig did this while serving as a director of a biotech startup that won $334 million in federal contracts to supply just such a drug, a Los Angeles Times investigation found (Willman, 5/19). This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.